Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance. [PDF]
Neeland IJ +24 more
europepmc +1 more source
Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care. [PDF]
Kämpe J +5 more
europepmc +1 more source
Equitable lipid optimisation through a data-driven, pharmacist-led secondary prevention pathway. [PDF]
Xu J +5 more
europepmc +1 more source
Association of PM2.5 exposure with 10-year atherosclerotic cardiovascular disease risk: a mediation analysis of blood and urinary biomarkers. [PDF]
Han Y +8 more
europepmc +1 more source
Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment in Young vs Older Adults.
Tang R +10 more
europepmc +1 more source
GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study. [PDF]
Mori T +7 more
europepmc +1 more source
Ketogenic Diets and Low-Density Lipoprotein Cholesterol in Adults With Normal Weight: An Emerging Clinical Challenge. [PDF]
DiMattia ZS, Petersen KS.
europepmc +1 more source
Ten-Year Cardiovascular Disease Risk Among Employees Aged 40 Years and Older at the University of Sharjah: A Cross-Sectional Study. [PDF]
Alhariri MM +5 more
europepmc +1 more source
Systemic Inflammation and Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease. [PDF]
Sandhu AT +10 more
europepmc +1 more source

